CORE SCIENTIFIC INC

Core Scientific insider sells 9,900 shares as part of a routine plan—investors see a cautious, not panic, move amid broader AI‑infrastructure market shifts.

Insider selling surge at Core Scientific signals a strategic divestment while confidence in long‑term value stays high—what this means for investors.

Core Scientific’s insider selling surge—over 500K shares in a year—signals executive confidence amid a 14.9% stock decline, offering cautious investors a nuanced view of risk and reward.

Weiss Eric Stanton buys 6,000 Core Scientific shares—showing steady, insider confidence in AI‑centric colocation and a cautiously optimistic outlook for the company.

Insight on Core Scientific’s insider selling: Todd M. Duchene’s Rule 10b‑5‑1 plan shows planned, modest sales that keep price stable while keeping the stock attractive for long‑term value investors.